Literature DB >> 12520098

Polymorphisms and the antiviral property of porcine Mx1 protein.

Atsushi Asano1, Jae Hong Ko, Takeya Morozumi, Noriyuki Hamashima, Tomomasa Watanabe.   

Abstract

We determined the cDNA sequences of the type I interferon-inducible proteins, pig Mx1 from PK(15) and LLC-PK1 cells, and compared the antiviral activities of both Mx proteins, including Mx1 polymorphisms against vesicular stomatitis virus (VSV). Mx1 cDNA derived from PK(15) cells had an 11 bp-deletion in the 3' end of the coding region, and was estimated to encode 8 amino acid substitutions and a 23 amino acid extension compared to that from LLC-PK1 cells. VSV replication was inhibited in the 3T3 cells expressing Mx1 mRNA after the cDNA was transfected. However, the efficiency of this inhibition was not different between the cells expressing Mx1 mRNA from both PK and LLC. These results indicate that pig Mx1 protein confers resistance to VSV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12520098     DOI: 10.1292/jvms.64.1085

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  18 in total

1.  The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus.

Authors:  Susan L Brockmeier; Crystal L Loving; Eric A Nelson; Laura C Miller; Tracy L Nicholson; Karen B Register; Marvin J Grubman; Douglas E Brough; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

2.  Association of multi-pathogenic infections with BAT2, CXCL12, Mx1 and EHMT2 variations in pigs.

Authors:  S J Wang; W J Liu; L G Yang; H B Liu; C A Sargent; N A Affara; S J Zhang
Journal:  Mol Biol Rep       Date:  2012-04-25       Impact factor: 2.316

Review 3.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

4.  "Self" and "nonself" manipulation of interferon defense during persistent infection: bovine viral diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells.

Authors:  Matthias Schweizer; Philippe Mätzener; Gabriela Pfaffen; Hanspeter Stalder; Ernst Peterhans
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Effects of the polymorphisms of Mx1, BAT2 and CXCL12 genes on immunological traits in pigs.

Authors:  S J Wang; W J Liu; C A Sargent; S H Zhao; H B Liu; X D Liu; C Wang; G H Hua; L G Yang; N A Affara; S J Zhang
Journal:  Mol Biol Rep       Date:  2011-06-12       Impact factor: 2.316

6.  Inhibition of infectious pancreatic necrosis virus replication by atlantic salmon Mx1 protein.

Authors:  Rannveig Larsen; Torunn P Røkenes; Børre Robertsen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  A single nucleotide polymorphism of porcine MX2 gene provides antiviral activity against vesicular stomatitis virus.

Authors:  Keisuke Sasaki; Pullop Tungtrakoolsub; Takeya Morozumi; Hirohide Uenishi; Manabu Kawahara; Tomomasa Watanabe
Journal:  Immunogenetics       Date:  2014-01       Impact factor: 2.846

8.  African swine fever virus multigene family 360 and 530 genes affect host interferon response.

Authors:  C L Afonso; M E Piccone; K M Zaffuto; J Neilan; G F Kutish; Z Lu; C A Balinsky; T R Gibb; T J Bean; L Zsak; D L Rock
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Porcine Mx1 Protein Inhibits Classical Swine Fever Virus Replication by Targeting Nonstructural Protein NS5B.

Authors:  Jing Zhou; Jing Chen; Xiao-Min Zhang; Zhi-Can Gao; Chun-Chun Liu; Yun-Na Zhang; Jin-Xiu Hou; Zhao-Yao Li; Lin Kan; Wen-Liang Li; Bin Zhou
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

10.  Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein.

Authors:  Benjamin Mänz; Dominik Dornfeld; Veronika Götz; Roland Zell; Petra Zimmermann; Otto Haller; Georg Kochs; Martin Schwemmle
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.